Cytokinetics (CYTK) Regains Nasdaq Listing Compliance
Tweet Send to a FriendGet Alerts CYTK Hot Sheet
Up)
Trade CYTK Now!
On January 24, 2013, Cytokinetics, Incorporated (Nasdaq: CYTK) received a notice from The Nasdaq Stock Market ("Nasdaq") confirming that for the last 10 consecutive business days, the closing bid price of the Company’s common stock has been at $1.00 per share or greater. Accordingly, the Company has regained compliance with Listing Rule 5450(a)(1).
As previously reported, the Company received notice from Nasdaq on June 18, 2012 that the Company’s common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. On December 18, 2012, the Company transferred its listing to the Nasdaq Capital Market and Nasdaq provided the Company until June 17, 2013 to achieve compliance with the Listing Rule 5450(a)(1) requirement.
Nasdaq has informed the Company that this matter is now closed.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
As previously reported, the Company received notice from Nasdaq on June 18, 2012 that the Company’s common stock had failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. On December 18, 2012, the Company transferred its listing to the Nasdaq Capital Market and Nasdaq provided the Company until June 17, 2013 to achieve compliance with the Listing Rule 5450(a)(1) requirement.
Nasdaq has informed the Company that this matter is now closed.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Acacia Research (ACTG) Enters Settlement with Red Hat (RHT)
- Dean Foods (DF) Completes WhiteWave (WWAV) Spin-Off
- Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal
Create E-mail Alert Related Categories
Corporate News
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
